Sharing our research at the 2024 Tobacco Science Research Conference

Harm Reduction
Science & Data
Scientific Engagement
Library

Harm Reduction

To support our scientific efforts, we established a rigorous scientific framework based on the FDA's guidance to evaluate potentially reduced-harm tobacco products.

Posters and Publications

Learn More

Science & Data

Science is at the core of our approach to Tobacco Harm Reduction. Investments in research and technology support our work on smoke-free platforms and the science needed for product applications submitted to the U.S. Food and Drug Administration.

Two people looking at a laptop, seated in comfortable chairs at a table before a full glass wall with daylight shining through and a potted tree behind them.

Scientific Engagement

We engage with the scientific and public health community through face-to-face meetings, publications in the scientific literature and participation in scientific conferences.

Library

Our goal is to be transparent and we invite scientific review from and dialogue with scientists, the public health and regulatory communities about our scientific work.

Posters and Presentations

Learn More

Altria Scientists joined stakeholders from industry, public health, and FDA in Atlanta on September 9-11 at the 77^th Tobacco Science Research Conference. During the three-day conference, our scientists showcased their collective expertise and shared science supporting the role of smoke-free products in advancing harm reduction.

Dr. Vergara gave a compelling presentation entitled "Menthol, Blueberry, and Watermelon NJOY ACE Promotes Significantly Greater Complete Switching Compared to Tobacco-flavored NJOY ACE". During her presentation, Dr. Vergara shared a summary of evidence submitted to FDA that led to FDA’s determination of the NJOY Menthol being “appropriate for the protection of public health.” She also presented findings from the NJOY ACE 2.0 Bluetooth enabled PMTA submitted to FDA earlier this year.

Dr. Vergara also participated on the panel, “Weight of the Evidence: Assessing the Benefits of Smokefree Alternatives to Adults Who Smoke and the Risk of Underage Initiation.” Her presentation featured research demonstrating the benefit to the population of current smokers who completely switched to NJOY ACE.

Dr. Hong presented his poster entitled "Characterization of Nicotine Pharmacokinetics and Subjective Effects During Use of Heated Tobacco Products in Adults Who Smoke".

He shared how the data suggests the prototype Ploom® System can potentially provide U.S. adults who smoke with an option to advance tobacco harm reduction.

Two men standing in front of a scientific poster looking intently at it

Elizabeth and Jenny shared their poster "Perceptions of Risk of the Marlboro Heated Tobacco Stick Products Used with the Ploom^® Heated Tobacco Device among US Adults". They shared results of the appropriate understanding among intended and unintended audiences of the risks and potential benefits of the Ploom^® System to adult smokers. Elizabeth and Jenny also shared how we believe the research supports a determination of "appropriate for the protection of public health" and may facilitate switching to a potentially reduced harm product.

We invite you to view the rest of the posters and presentations from the TSRC conference to see our latest research.

Harm Reduction

Science & Data

Scientific Engagement

Library

Sharing our research at the 2024 TSRC